SB Teams With Glaxo, Implying Pressure on Biotech Deal Prices
The Glaxo-SmithKline partnership to pursue bacterial genomics isn't the first research-stage alliance between large companies-indeed more of them are being signed as large companies decide to share the costs of drug research.
You may also be interested in...
Following the announcement in the US that ranitidine drugs must be withdrawn from the market, the European Medicines Agency told the Pink Sheet it would decide on the fate of these medicines in the EU after wrapping up its own inquiry.
In addition to our daily in-depth coverage of key events relating to the COVID-19 pandemic, we’re bringing you a periodic round-up of other developments. This edition covers Europe and other countries.
EU drug industry federation, EFPIA, is concerned that an increase in protectionist trade measures by some countries could result in tit-for-tat policies that could hamper the global response to contain COVID-19.